Clinical Trial Update: Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing topical imiquimod to conization for cervical intraepithelial neoplasia was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• Aldara (imiquimod)

Snippet

Sponsor: Medical University of Vienna | Conditions: Cervical Intraepithelial Neoplasia | Phase 3 | Status: TERMINATED